Moprolol

Moprolol ((±) -Moprolol) is an beta-adrenergic receptor blocker, which can be used for research in essential hypertension[1][2][3].

Product Specifications

CAS Number

[5741-22-0]

Product Name Alternative

(±) -Moprolol

UNSPSC

12352005

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Others; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/moprolol.html

Solubility

10 mM in DMSO

Smiles

OC(CNC(C)C)COC1=CC=CC=C1OC

Molecular Formula

C13H21NO3

Molecular Weight

239.31

References & Citations

[1]Borowiecki P, et al. Development of a novel chemoenzymatic route to enantiomerically enriched β-adrenolytic agents. A case study toward propranolol, alprenolol, pindolol, carazolol, moprolol, and metoprolol. RSC Adv. 2022 Aug 10;12 (34) :22150-22160. |[2]Liu J, et al. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin Pharmacol Ther. 2006 Jul;80 (1) :23-32. |[3]Rossetti L, et al. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1994 Nov;232 (11) :670-4.